Johnson & Johnson Vision Care announced that the FDA has approved its Acuvue Theravision with Ketotifen daily disposable contact lenses.
Each lens is made of etafilcon A material and contains 19 mcg of the antihistamine ketotifen, the company said in a press release. Already available to patients in Japan and Canada, these are the first drug-eluting contact lenses approved by the FDA.
The company stated that Acuvue Theravision with Ketotifen daily disposable lenses are “indicated for the prevention of ocular itch due to allergic conjunctivitis and provide vision correction in patients